Results
|
3061.
|
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial. [electronic resource] by
- Lee, Myungsun
- Mok, Jeongha
- Kim, Deog Kyeom
- Shim, Tae Sun
- Koh, Won-Jung
- Jeon, Doosoo
- Lee, Taehoon
- Lee, Seung Heon
- Kim, Ju Sang
- Park, Jae Seuk
- Lee, Ji Yeon
- Kim, Song Yee
- Lee, Jae Ho
- Jo, Kyung-Wook
- Jhun, Byung Woo
- Kang, Young Ae
- Ahn, Joong Hyun
- Kim, Chang-Ki
- Shin, Soyoun
- Song, Taeksun
- Shin, Sung Jae
- Kim, Young Ran
- Ahn, Heejung
- Hahn, Seokyung
- Won, Ho Jeong
- Jang, Ji Yeon
- Cho, Sang Nae
- Yim, Jae-Joon
Producer: 20190531
In:
Trials vol. 20
Availability: No items available.
|
|
3062.
|
|
|
3063.
|
|
|
3064.
|
|
|
3065.
|
|
|
3066.
|
|
|
3067.
|
|